ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.

Abstract:

:During 2007, approximately 200,000 people in the United States will be diagnosed with brain tumors. Gliomas account for 77% of primary malignant brain tumors, and the prognosis has hardly changed in the past 20 years, with only 30% of patients with malignant glioma surviving 5 years after diagnosis. Oncolytic adenoviruses are promising therapies for the treatment of gliomas. Here, report the antiglioma activity of the tumor-selective ICOVIR-5 adenovirus, which encompasses an early 1A adenoviral (E1A) deletion in the retinoblastoma (Rb) protein-binding region, substitution of the E1A promoter for E2F-responsive elements, and an RGD-4C peptide motif inserted into the adenoviral fiber to enhance adenoviral tropism. Mechanistic studies showed a dramatic addiction of ICOVIR-5 to the E2F1 oncogene in vitro and in vivo. This addiction was mediated by the occupancy of the ectopic adenoviral E2F1-responsive elements by the endogenous E2F1 protein resulting in high level of E1A expression in cancer cells and potent antiglioma effect. Importantly, we showed for the first time the ability of oncolytic adenoviruses to enhance E2F transcriptional activity in vivo, and we provided direct evidence of the interaction of the E2F1 protein with native and ectopic adenovirus promoters. Restoration of Rb function led to the association of Rb/E2F1 repressor complexes with ICOVIR-5 ectopic E2F1 promoter and subsequent down-modulation of E1A, dramatically impairing adenoviral replication. In xenografted mice, intratumoral injection of ICOVIR-5 resulted in a significant improvement of the median survival (P < 0.0001), and furthermore, led to 37% of long-term survivors free of disease. The antitumor activity of ICOVIR-5 suggests that it has the potential to be an effective agent in the treatment of gliomas.

journal_name

Cancer Res

journal_title

Cancer research

authors

Alonso MM,Cascallo M,Gomez-Manzano C,Jiang H,Bekele BN,Perez-Gimenez A,Lang FF,Piao Y,Alemany R,Fueyo J

doi

10.1158/0008-5472.CAN-06-4675

subject

Has Abstract

pub_date

2007-09-01 00:00:00

pages

8255-63

issue

17

eissn

0008-5472

issn

1538-7445

pii

67/17/8255

journal_volume

67

pub_type

杂志文章
  • Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.

    abstract::Busulfan (1,4-butanediol dimethanesulfonate, BU) is relatively unique among other standard chemotherapy compounds in its ability to deplete noncycling primitive stem cells in the host and consequently to allow for high levels of long-term, donor-type engraftment after bone marrow transplantation (BMT). Such a property...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Westerhof GR,Ploemacher RE,Boudewijn A,Blokland I,Dillingh JH,McGown AT,Hadfield JA,Dawson MJ,Down JD

    更新日期:2000-10-01 00:00:00

  • MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers.

    abstract::Transcriptional regulator YAP is activated in multiple human cancers and plays critical roles in tumor initiation, progression, metastasis, and drug resistance. However, therapeutic targeting of the Hippo-YAP pathway has been challenging due to its low druggability and limited knowledge of YAP regulation in cancer. He...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1339

    authors: Seo J,Kim MH,Hong H,Cho H,Park S,Kim SK,Kim J

    更新日期:2019-12-15 00:00:00

  • T lymphocytes restrain spontaneous metastases in permanent dormancy.

    abstract::Tumor dormancy is a clinical phenomenon related to immune equilibrium during cancer immunoediting. The mechanisms involved in dormant metastases are poorly understood due to the lack of preclinical models. Here, we present a nontransgenic mouse model in which spontaneous metastases remain in permanent immunomediated d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-2084

    authors: Romero I,Garrido C,Algarra I,Collado A,Garrido F,Garcia-Lora AM

    更新日期:2014-04-01 00:00:00

  • DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.

    abstract::In a previous genomic analysis, using somatic methyltransferase (DNMT) knockout cells, we showed that hypomethylation decreased the expression of as many genes as were observed to increase, suggesting a previously unknown mechanism for epigenetic regulation. To address this idea, the expression of the BAG family genes...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6654

    authors: Sun L,Huang L,Nguyen P,Bisht KS,Bar-Sela G,Ho AS,Bradbury CM,Yu W,Cui H,Lee S,Trepel JB,Feinberg AP,Gius D

    更新日期:2008-04-15 00:00:00

  • Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.

    abstract::Pharmacokinetic studies of 5-fluorouracil (5-FUra) were performed on 18 patients divided into three groups: seven patients were given 5-FUra i.v. by rapid injection; five patients received the drug p.o.; and six patients were treated by continuous i.v. infusion for 96 hr. The results showed rapid i.v. injection to be ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fraile RJ,Baker LH,Buroker TR,Horwitz J,Vaitkevicius VK

    更新日期:1980-07-01 00:00:00

  • Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR.

    abstract::We have used genome-wide allelotyping with 348 polymorphic autosomal markers spaced, on average, 10 cM apart to quantitate the extent of intrachromosomal instability in 59 human sporadic colorectal carcinomas. We have compared instability measured by this method with that measured by inter-(simple sequence repeat) PCR...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Anderson GR,Brenner BM,Swede H,Chen N,Henry WM,Conroy JM,Karpenko MJ,Issa JP,Bartos JD,Brunelle JK,Jahreis GP,Kahlenberg MS,Basik M,Sait S,Rodriguez-Bigas MA,Nowak NJ,Petrelli NJ,Shows TB,Stoler DL

    更新日期:2001-11-15 00:00:00

  • Hypermutability of UV-treated plasmids in dysplastic nevus/familial melanoma cell lines.

    abstract::Members of cutaneous melanoma (CM) families with dysplastic nevi (DN) are at high risk of developing CM. Using a shuttle vector plasmid, pSP189, cell lines from three patients with CM plus DN were previously found to have elevated post-UV plasmid mutability. To investigate familial occurrence of this cellular phenotyp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Moriwaki SI,Tarone RE,Tucker MA,Goldstein AM,Kraemer KH

    更新日期:1997-10-15 00:00:00

  • Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.

    abstract::We have shown that cyclophosphamide (CY) can augment the development of delayed-type hypersensitivity to a primary antigen in patients with advanced cancer. In the present study, we administered CY (1000 mg/sq m) to 19 patients with advanced, metastatic cancer and monitored the compositional and functional changes in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berd D,Maguire HC Jr,Mastrangelo MJ

    更新日期:1984-03-01 00:00:00

  • Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.

    abstract::Low income, poor diet, obesity, and a lack of exercise are interrelated lifestyle factors that can profoundly alter our biologic make up to increase cancer risk, growth, and development. We recently reported a potential mechanistic link between carbohydrate-derived metabolites and cancer, which may provide a biologic ...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-15-0169

    authors: Turner DP

    更新日期:2015-05-15 00:00:00

  • Drug sequence-dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine.

    abstract::The toxicity to mice of combinations of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine was investigated. The drugs were administered daily i.p. on Days 1 to 5, each drug at 10 mg/kg body weight; these dosages are small fractions of the dosages at which 10% of the treated animals died when either drug was adminis...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Paterson AR,Jakobs ES,Lauzon GJ,Weinstein WM

    更新日期:1979-06-01 00:00:00

  • Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.

    abstract::Increasing the expression of c-FMS (colony-stimulating factor 1 receptor) by introduction of a transgene reduced the concentration of retinoic acid or 1,25-dihydroxy vitamin D3 needed to cause myeloid or monocytic cell differentiation and hypophosphorylation of the retinoblastoma tumor suppressor protein (RB) typicall...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yen A,Sturgill R,Varvayanis S

    更新日期:1997-05-15 00:00:00

  • Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.

    abstract::Insulin receptor (IR) exists as two isoforms resulting from the alternative splicing of IR pre-mRNA. IR-B promotes the metabolic effects of insulin, whereas IR-A rather signals proliferative effects. IR-B is predominantly expressed in the adult liver. Here, we show that the alternative splicing of IR pre-mRNA is dysre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-3824

    authors: Chettouh H,Fartoux L,Aoudjehane L,Wendum D,Clapéron A,Chrétien Y,Rey C,Scatton O,Soubrane O,Conti F,Praz F,Housset C,Rosmorduc O,Desbois-Mouthon C

    更新日期:2013-07-01 00:00:00

  • Medullary thyroid carcinoma arises in the absence of prolactin signaling.

    abstract::Prolactin, a pituitary hormone, exerts pleiotropic effects in various cells. These effects are mediated by a membrane receptor highly expressed in many tissues. To analyze prolactin effects on the thyroid gland, we first identified prolactin receptor (PRLR) mRNAs by in situ hybridization. To further evaluate the physi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3937

    authors: Kedzia C,Lacroix L,Ameur N,Ragot T,Kelly PA,Caillou B,Binart N

    更新日期:2005-09-15 00:00:00

  • Correlation of amino acid fucoside labeling patterns with tumorigenicity of mouse mammary epithelial cells.

    abstract::The amino acid fucosides of tumorigenic and nontumorigenic mouse mammary gland-derived cells were studied. The cells examined included tumorigenic cell lines derived from mammary carcinomas of the following etiologies: induction by hormone; virus; and chemical carcinogen. Also studied were cells derived from normal ma...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Steiner MR,Richards CS,Butel JS,Medina D

    更新日期:1983-06-01 00:00:00

  • Isolation of variant cells from SV-40 transformed human diploid fibroblasts.

    abstract::Variant cell lines that are sensitive to density-dependent inhibition of growth have been isolated from three of four SV40-transformed human fibroblast cell lines. Variants were isolated by plating the transformed cells at low density, by treating them with 5-fluorodeoxyuridine, or by growing them on glutaraldehyde-fi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosenberg N,Schaeffer WI,Diamond L

    更新日期:1975-08-01 00:00:00

  • VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma.

    abstract::Glioblastoma multiforme (GBM) is characterized by a pathogenic vasculature that drives aggressive local invasion. Recent work suggests that GBM cells recruit bone marrow-derived progenitor cells (BMDC) to facilitate recurrence after radiotherapy, but how this may be achieved is unclear. In this study, we established t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3119

    authors: Burrell K,Singh S,Jalali S,Hill RP,Zadeh G

    更新日期:2014-07-15 00:00:00

  • Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.

    abstract::The interactions of tumorigenic cells with the extracellular matrix play a critical role in the establishment of metastases. Thrombospondin (TSP) is prominent at sites of tissue injury and promotes the attachment, spreading, and motility of several cell types. We have investigated the relationship between human carcin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yabkowitz R,Mansfield PJ,Dixit VM,Suchard SJ

    更新日期:1993-01-15 00:00:00

  • Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.

    abstract::The identification of proteins that are preferentially expressed on the membrane of metastatic tumor cells is of fundamental importance in cancer research. Here, we report the systematic comparison of the membrane proteome of two closely related murine teratocarcinoma cell lines (F9B9 and F9DR), of which only one (F9D...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0999

    authors: Roesli C,Borgia B,Schliemann C,Gunthert M,Wunderli-Allenspach H,Giavazzi R,Neri D

    更新日期:2009-07-01 00:00:00

  • p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

    abstract::The INK4a/ARF locus encodes two distinct tumor suppressors, p16INK4a and p14ARF. Although the contribution of p16INK4a to human tumorigenesis through point mutation, deletion, and hypermethylation has been widely documented, little is known about specific p14ARF lesions and their consequences. Recent data indicate tha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Esteller M,Cordon-Cardo C,Corn PG,Meltzer SJ,Pohar KS,Watkins DN,Capella G,Peinado MA,Matias-Guiu X,Prat J,Baylin SB,Herman JG

    更新日期:2001-04-01 00:00:00

  • Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.

    abstract::In a European joint project carried out in 6 laboratories a disease-oriented program was set up consisting of a panel of 7 tumor types, each represented by 4 to 8 different human tumor lines, for secondary screening of promising anticancer drugs. Human tumor lines were selected on the basis of differences in histology...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Boven E,Winograd B,Berger DP,Dumont MP,Braakhuis BJ,Fodstad O,Langdon S,Fiebig HH

    更新日期:1992-11-01 00:00:00

  • Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development.

    abstract::A rat lung cell population had been treated with benzo(a)pyrene, and a set of different epithelial cell lines was derived from it. These cell lines carried either a wild-type or mutant p53 gene and represented grading states of neoplastic development. We demonstrate here that the cells lacking both wild-type p53 allel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Biard DS,Martin M,Rhun YL,Duthu A,Lefaix JL,May E,May P

    更新日期:1994-07-01 00:00:00

  • Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

    abstract::In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib. Nevertheless, resistance or intolerance to imatinib and other BCR/ABL inhibitors may occur during therapy. Therefore, CML research is focusing on novel targets and targeted drugs. Po...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2181

    authors: Gleixner KV,Ferenc V,Peter B,Gruze A,Meyer RA,Hadzijusufovic E,Cerny-Reiterer S,Mayerhofer M,Pickl WF,Sillaber C,Valent P

    更新日期:2010-02-15 00:00:00

  • Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action.

    abstract::Endometrial carcinoma is associated with antecedent simple and complex hyperplasia, and the endometrium is a target tissue for the action of cytokines and growth factors. Transforming growth factor (TGF)-beta s are potent cellular growth and differentiation regulatory factors. Therefore, we investigated the potential ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gold LI,Saxena B,Mittal KR,Marmor M,Goswami S,Nactigal L,Korc M,Demopoulos RI

    更新日期:1994-05-01 00:00:00

  • Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.

    abstract::Lung carcinoma cell lines were analyzed in culture and in nude mouse xenograft for both morphological appearance and expression of specific proteins that participate in cross-linked envelope formation during normal squamous cell terminal differentiation. Cross-linked envelope formation, induced by artificial influx of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Levitt ML,Gazdar AF,Oie HK,Schuller H,Thacher SM

    更新日期:1990-01-01 00:00:00

  • Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort.

    abstract::Loss of imprinting (LOI) of the insulin-like growth factor II (IGFII) gene is a frequent phenomenon in colorectal tumor tissues. Previous reports indicated that subjects with colorectal neoplasias show LOI of IGFII in circulating lymphocytes. Furthermore, LOI of IGFII is strongly related to the methylation of a differ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-3020

    authors: Kaaks R,Stattin P,Villar S,Poetsch AR,Dossus L,Nieters A,Riboli E,Palmqvist R,Hallmans G,Plass C,Friesen MD

    更新日期:2009-07-01 00:00:00

  • Androgen sensitivity of the new human breast cancer cell line MFM-223.

    abstract::The mammary carcinoma cell line MFM-223 is characterized by high androgen and low estrogen and progesterone receptor levels. With the dextran charcoal method, androgen binding was determined at 160 fmol/mg protein corresponding to approximately 100,000 binding sites per cell in whole cell binding assays. The estrogen ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hackenberg R,Lüttchens S,Hofmann J,Kunzmann R,Hölzel F,Schulz KD

    更新日期:1991-10-15 00:00:00

  • Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.

    abstract::Reduced expression of neural cell adhesion molecule (NCAM) has been implicated in the progression to tumor malignancy in cancer patients. Previously, we have shown that the loss of NCAM function causes the formation of lymph node metastasis in a transgenic mouse model of pancreatic beta cell carcinogenesis (Rip1Tag2)....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2523

    authors: Crnic I,Strittmatter K,Cavallaro U,Kopfstein L,Jussila L,Alitalo K,Christofori G

    更新日期:2004-12-01 00:00:00

  • Mechanisms of Taxol-induced cell death are concentration dependent.

    abstract::Although the ability of Taxol to stabilize cellular microtubules is well accepted, the mechanisms by which Taxol induces growth arrest and cell death remain unclear. Recent evidence indicates that Taxol alters specific intracellular signal transduction events, such as the activation of Raf-1 kinase, that may be essent...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Torres K,Horwitz SB

    更新日期:1998-08-15 00:00:00

  • Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

    abstract::Although trastuzumab (Herceptin) has substantially improved the overall survival of patients with mammary carcinomas, even initially well-responding tumors often become resistant. Because natural killer (NK) cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) is thought to contribute to the therapeutic ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0834

    authors: Reim F,Dombrowski Y,Ritter C,Buttmann M,Häusler S,Ossadnik M,Krockenberger M,Beier D,Beier CP,Dietl J,Becker JC,Hönig A,Wischhusen J

    更新日期:2009-10-15 00:00:00

  • Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta.

    abstract::Pancreatic ductal carcinoma is characterized by a profound chemoresistance. As we have shown previously, these tumor cells can develop chemoresistance by interleukin (IL)-1beta in an autocrine and nuclear factor-kappaB-dependent fashion. Because pancreatic ductal carcinoma contains many mesenchymal stromal cells, we f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-1860

    authors: Müerköster S,Wegehenkel K,Arlt A,Witt M,Sipos B,Kruse ML,Sebens T,Klöppel G,Kalthoff H,Fölsch UR,Schäfer H

    更新日期:2004-02-15 00:00:00